1622 Federal Register / Vol. 83, No. 9 / Friday, January 12, 2018 / Notices 

Contact Person: Julia Berzhanskaya, Ph.D., 

Scientific Review Officer, Office of 

Extramural Policy and Review, Division of 

Extramural Research, National Institute on 

Drug Abuse, NIH, DHHS, 6001 Executive 

Boulevard, Room 4234, MSC 9550, Bethesda, 

MD 20892, 301–827–5840, 

julia.berzhanskaya@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No.: 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: January 9, 2018. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–00445 Filed 1–11–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Fogarty International Center; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Fogarty International 

Center Advisory Board. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Fogarty 

International Center Advisory Board. 

Date: February 12–13, 2018. 

Place: National Institutes of Health 

Lawton L. Chiles International House 

(Stone House), Building 16, Conference 

Room, 16 Center Drive, Bethesda, MD 

20892. 

Closed Session: February 12, 2018, 

2:00 p.m. to 5:00 p.m. 

Agenda: Second level review of grant 

applications. 

Date: February 13, 2018. 

Place: National Institutes of Health. 

Lawton L. Chiles International House 

(Stone House), Building 16, Conference 

Room, 16 Center Drive, Bethesda, MD 

20892. 

Open Session: February 13, 2018, 9:00 

a.m. to 3:00 p.m. 

Agenda: Update and discussion of 

current and planned FIC activities. 

Contact Person: Kristen Weymouth, 

Executive Secretary, Fogarty 

International Center, National Institutes 

of Health, 31 Center Drive, Room 

B2C02, Bethesda, MD 20892, (301) 496– 

1415, kristen.weymouth@nih.gov. 

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for 

entrance onto the NIH campus. All 

visitor vehicles, including taxicabs, 

hotel, and airport shuttles will be 

inspected before being allowed on 

campus. Visitors will be asked to show 

one form of identification (for example, 

a government-issued photo ID, driver’s 

license, or passport) and to state the 

purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: http://

www.fic.nih.gov/About/Advisory/Pages/ 

default.aspx, where an agenda and any 

additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic 

Assistance Program Nos. 93.106, 

Minority International Research 

Training Grant in the Biomedical and 

Behavioral Sciences; 93.154, Special 

International Postdoctoral Research 

Program in Acquired Immunodeficiency 

Syndrome; 93.168, International 

Cooperative Biodiversity Groups 

Program; 93.934, Fogarty International 

Research Collaboration Award; 93.989, 

Senior International Fellowship Awards 

Program, National Institutes of Health, 

HHS) 

Dated: January 9, 2018. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–00440 Filed 1–11–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, 

Development of Portable Neuromodulatory 

Devices for the Treatment of Substance Use 

Disorders (8941). 

Date: January 17, 2018. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: Julia Berzhanskaya, Ph.D., 

Scientific Review Officer, Office of 

Extramural Policy and Review, Division of 

Extramural Research, National Institute on 

Drug Abuse, NIH, DHHS, 6001 Executive 

Boulevard, Room 4234, MSC 9550, Bethesda, 

MD 20892, 301–827–5840, 

julia.berzhanskaya@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program No.: 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: January 9, 2018. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–00444 Filed 1–11–18; 8:45 am] 

BILLING CODE 4140–01–P 


sradovich on DSK3GMQ082PROD with NOTICES